Long-term survival and biomarkers of immunotherapy in small cell lung cancer: a systematic review.

Saved in:
Bibliographic Details
Title: Long-term survival and biomarkers of immunotherapy in small cell lung cancer: a systematic review.
Authors: Laguna S; Medical Oncology Department, University Hospital of Navarra, Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.; Medical Oncology Department, Hospital General San Jorge, Huesca, Spain., Sádaba A; Medical Oncology Department, University Hospital of Navarra, Navarra Institute for Health Research (IdiSNA), Pamplona, Spain., Morilla I; Medical Oncology Department, University Hospital of Navarra, Navarra Institute for Health Research (IdiSNA), Pamplona, Spain., Teijeira L; Medical Oncology Department, University Hospital of Navarra, Navarra Institute for Health Research (IdiSNA), Pamplona, Spain., Martínez-Aguillo M; Medical Oncology Department, University Hospital of Navarra, Navarra Institute for Health Research (IdiSNA), Pamplona, Spain., Huerta-Hernández AE; Translational Medical Oncology Unit, Navarrabiomed-IdiSNA, Pamplona, Spain., Labiano I; Translational Medical Oncology Unit, Navarrabiomed-IdiSNA, Pamplona, Spain., Lecumberri A; Medical Oncology Department, University Hospital of Navarra, Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.; Translational Medical Oncology Unit, Navarrabiomed-IdiSNA, Pamplona, Spain., Cáseda I; Translational Medical Oncology Unit, Navarrabiomed-IdiSNA, Pamplona, Spain., Redrado M; Program in Solid Tumors, CIMA-Universidad de Navarra, Cancer Center Clinica Universidad de Navarra (CCUN), IdiSNA, Pamplona, Spain., Artola M; Program in Solid Tumors, CIMA-Universidad de Navarra, Cancer Center Clinica Universidad de Navarra (CCUN), IdiSNA, Pamplona, Spain., Termini R; Translational Medical Oncology Unit, Navarrabiomed-IdiSNA, Pamplona, Spain., Agra C; Medical Oncology Department, University Hospital of Navarra, Navarra Institute for Health Research (IdiSNA), Pamplona, Spain., Otegui N; Program in Solid Tumors, CIMA-Universidad de Navarra, Cancer Center Clinica Universidad de Navarra (CCUN), IdiSNA, Pamplona, Spain., Calvo A; Program in Solid Tumors, CIMA-Universidad de Navarra, Cancer Center Clinica Universidad de Navarra (CCUN), IdiSNA, Pamplona, Spain., Beunza-Sola M; Pharmacy Department, Hospital Universitario de Navarra, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain., Castro N; Medical Oncology Department, Clínica Universidad de Navarra, Pamplona, Spain., Vera R; Medical Oncology Department, University Hospital of Navarra, Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.; Translational Medical Oncology Unit, Navarrabiomed-IdiSNA, Pamplona, Spain., Alsina M; Medical Oncology Department, University Hospital of Navarra, Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.; Translational Medical Oncology Unit, Navarrabiomed-IdiSNA, Pamplona, Spain., Arasanz H; Medical Oncology Department, University Hospital of Navarra, Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.; Translational Medical Oncology Unit, Navarrabiomed-IdiSNA, Pamplona, Spain.
Source: Translational lung cancer research [Transl Lung Cancer Res] 2026 May 31; Vol. 15 (5), pp. 151. Date of Electronic Publication: 2026 May 26.
Publication Type: Journal Article; Review
Journal Info: Publisher: Pioneer Bioscience Publishing Company Country of Publication: China NLM ID: 101646875 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2218-6751 (Print) Linking ISSN: 22186751 NLM ISO Abbreviation: Transl Lung Cancer Res Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2218-6751
DOI:10.21037/tlcr-2025-1-1450